This is a preprint.
The microenvironment dictates glycocalyx construction and immune surveillance
- PMID: 37645943
- PMCID: PMC10462183
- DOI: 10.21203/rs.3.rs-3164966/v1
The microenvironment dictates glycocalyx construction and immune surveillance
Abstract
Efforts to identify anti-cancer therapeutics and understand tumor-immune interactions are built with in vitro models that do not match the microenvironmental characteristics of human tissues. Using in vitro models which mimic the physical properties of healthy or cancerous tissues and a physiologically relevant culture medium, we demonstrate that the chemical and physical properties of the microenvironment regulate the composition and topology of the glycocalyx. Remarkably, we find that cancer and age-related changes in the physical properties of the microenvironment are sufficient to adjust immune surveillance via the topology of the glycocalyx, a previously unknown phenomenon observable only with a physiologically relevant culture medium.
Keywords: ECM; Mechanopharmacology; bleb; glycoform; glycome; glycosylation; immune surveillance; lectin array; lectin microarray; mechano-metabolic; metabolism; microenvironment; sialic acid.
Conflict of interest statement
Competing Interests J.R.C. is an inventor on an issued patent for Human Plasma-Like Medium (HPLM) assigned to the Whitehead Institute (Application number: PCT/US2017/061377. Patent number: 11453858. Issue date: 09/27/2022)
Figures






